![Yasunobu Kai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yasunobu Kai is currently a Director at H3 Biomedicine, Inc. He previously worked as an Executive Officer & Chief Strategy Officer at Eisai Co., Ltd.
| Bedrijven | Functie | Begin |
|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| EISAI CO., LTD. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Eisai Co., Ltd.
 Eisai Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacturing and sales of prescription and over-the-counter drugs | Commercial Services |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
